Fastenate Technologies GmbH

Fastenate Technologies is focused on solving the challenges of bioprocessing and biopharmaceutical manufacturing with ground-breaking optical-based biophysical technologies.

We’re a spin-off of NanoTemper Technologies, known for creating first-of-kind technology to advance the research and development of small molecule and biologics-based therapies. At Fastenate, we’re expanding our reach into bioprocessing and biopharmaceutical manufacturing, applying our expertise and know-how from our experience at NanoTemper, to solve some of the industry’s toughest challenges — ultimately changing the way things are done.

As therapies become more complex, the need arises for new tools to handle the processing and manufacturing of them. It is our mission to create ground-breaking technologies to enable the production of these difficult-to-produce therapies, moving one step closer to our vision of creating a world where every disease is treatable.

We know that we can’t achieve this vision on our own and partnering with scientists, researchers, and engineers is so important. If you believe in our vision and are interested in pursuing a collaboration or partnership, we’d love to hear from you.